QIN Wan-zhao, HE Guang-yao
Objective: To predict the potential targets and signaling pathways of 14-thienyl methylene matrine (YYJ18), a matrine derivative, against Epstein-Barr virus (EBV) infection based on network pharmacology and molecular docking, and to provide a theoretical basis for subsequent research on its anti-EBV mechanism and drug development. Methods: The SMILES string of YYJ18 was retrieved from the PubChem database, and its potential targets were predicted via SwissTargetPrediction, SuperPred, SEA and NetInfer databases, respectively. EBV infection-related targets were collected from GeneCards, OMIM and DisGeNET databases using the keyword "Epstein-Barr virus infections". The intersection of the two target sets was obtained as common targets. A protein-protein interaction (PPI) network was constructed through the STRING database, and topological analysis and core target screening were performed using Cytoscape software. Gene Ontology (GO) functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted on the Weishengxin online platform. A "disease-pathway-target-drug" multi-level network was further established. Finally, molecular docking validation of YYJ18 with core targets was carried out on the CB-DOCK2 platform. Results: A total of 255 potential targets of YYJ18 and 3,124 EBV infection-related targets were identified, with 87 intersection targets. 18 core targets were screened from the PPI network, including PIK3R1, STAT3 and HSP90AA1. GO enrichment analysis revealed that biological processes mainly involved response to drug, response to peptide hormone, protein autophosphorylation and cellular response to polypeptide; cellular components mainly included membrane rafts, membrane microdomains, membrane regions and transferase complexes; molecular functions mainly covered protein serine/threonine kinase activity, protein tyrosine kinase activity and non-transmembrane protein tyrosine kinase activity. KEGG pathway enrichment analysis indicated that targets were predominantly enriched in the PD-L1/PD-1 pathway, PI3K-Akt signaling pathway and NF-κB signaling pathway. The constructed "disease-pathway-target-drug" network contained 42 EBV infection gene targets and 10 signaling pathway nodes. The potential key targets included NFKB1, CHUK and PIK3R1, and the core signaling pathways comprised the chemokine signaling pathway, HIF-1 signaling pathway and PD-L1/PD-1 pathway. Molecular docking results showed that YYJ18 could form stable binding conformations with all the above core targets, with good binding affinity. Conclusion: The matrine derivative YYJ18 may exert potential anti-EBV infection effects by acting on multiple core targets such as PIK3R1, STAT3 and HSP90AA1, and synergistically regulating multiple pathways closely associated with EBV infection, including PD-L1/PD-1 pathway, PI3K-Akt signaling pathway and NF-κB signaling pathway. This study provides theoretical basis and experimental clues for further elucidating the antiviral mechanism of YYJ18, and also offers reference for the research and development of multi-target anti-EBV drugs derived from natural products.